Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3 Sarcoma 1

Conditions

Interventions

Radiotherapy 35 Doxorubicin 30 Ifosfamide 29 Cyclophosphamide 24 Vincristine 23 Filgrastim 23 Etoposide 20 Temozolomide 14 Granulocyte Colony-Stimulating Factor 14 Dactinomycin 11 Cisplatin 11 Trabectedin 10 Methotrexate 10 Gene Expression Profiling 10 Radiation 9 Imatinib Mesylate 9 Surgical Procedures, Operative 8 Polymerase Chain Reaction 8 Irinotecan 8 Specimen Handling 7 Paclitaxel 7 Chemotherapy, Adjuvant 7 Mesna 6 Immunohistochemistry 6 Gemcitabine 6 Carmustine 6 Biopsy 6 sargramostim 5 pegfilgrastim 5 etoposide phosphate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × cabazitaxel × Sarcoma × Clear all

NCT01913652 2021-09-14

Ph II Cabazitaxel DD Liposarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡